Based on miRNA-137 interactions, we can conclude that SLC22A18 has a potential oncogenic role and may be useful as a diagnostic and prognostic biomarker in NSCLC [78]. This evidence concerns the gene SLC67A1 and non-small cell lung carcinoma.